AbCellera Biologics Ownership | Who Owns AbCellera Biologics?
AbCellera Biologics Ownership Summary
AbCellera Biologics is owned by 39.70% institutional investors, 21.49% insiders, and 38.82% retail investors. Baker bros. advisors lp is the largest institutional shareholder, holding 10.14% of ABCL shares. American Funds SMALLCAP World A is the top mutual fund, with 4.08% of its assets in AbCellera Biologics shares.
ABCL Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | AbCellera Biologics | 39.70% | 21.49% | 38.82% |
| Sector | Healthcare Stocks | 129.40% | 12.08% | -41.48% |
| Industry | Biotech Stocks | 181.71% | 11.69% | -93.40% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Baker bros. advisors lp | 30.28M | 10.14% | $105.66M |
| Capital world investors | 13.58M | 4.44% | $198.12M |
| Two sigma investments, lp | 10.56M | 3.54% | $36.86M |
| Td waterhouse canada | 9.56M | 3.20% | $33.57M |
| Marshall wace, llp | 8.96M | 2.93% | $130.70M |
| Ubs asset management americas | 7.58M | 2.54% | $26.44M |
| Blackrock funding, inc. /de | 5.66M | 1.85% | $82.59M |
| Two sigma advisers, lp | 4.80M | 1.61% | $24.14M |
| Arrowmark colorado | 4.11M | 1.37% | $14.33M |
| Driehaus capital management | 4.02M | 1.35% | $14.05M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Intellectus partners | 584.13K | 1.42% | $8.52M |
| Guardian partners | 1.79M | 0.90% | $10.65B |
| Baker bros. advisors lp | 30.28M | 0.61% | $105.66M |
| Guardian capital advisors lp | 1.79M | 0.53% | $5.00M |
| Tang capital management | 2.60M | 0.50% | $13.08M |
| Arrowmark colorado | 4.11M | 0.38% | $14.33M |
| Neo ivy capital management | 118.19K | 0.38% | $1.72M |
| Brandywine managers | 28.49K | 0.20% | $415.64K |
| Virtus investment advisers | 60.56K | 0.20% | $883.57K |
| Networth advisors | 22.53K | 0.19% | $328.65K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Td waterhouse canada | 9.56M | 0.10% | 9.54M |
| Marshall wace, llp | 8.96M | 0.11% | 7.06M |
| Two sigma investments, lp | 10.56M | 0.03% | 4.75M |
| Baker bros. advisors lp | 30.28M | 0.61% | 2.75M |
| Jefferies financial group | 2.75M | 0.07% | 2.75M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Baillie gifford | - | - | -10.42M |
| Founders fund vii management | - | - | -3.77M |
| Orbimed advisors | - | - | -3.34M |
| Prosight management, lp | - | - | -2.82M |
| Casdin capital | - | - | -2.36M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Jefferies financial group | 2.75M | 0.07% | 2.75M | $9.58M |
| Alyeska investment group | 2.59M | 0.03% | 2.59M | $9.05M |
| Franklin resources | 1.54M | 0.00% | 1.54M | $18.91M |
| Pictet asset management sa | 275.90K | 0.00% | 275.90K | $4.09M |
| Voya investment management | 188.01K | 0.00% | 188.01K | $2.74M |
Sold Out
| Holder | Change |
|---|---|
| Clearstead advisors | -26.00 |
| Gamma investing | -46.00 |
| Morton brown family wealth | -75.00 |
| Atticus wealth management | -100.00 |
| Gill capital partners | -100.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | 172 | 2.38% | 121,292,234 | 4.46% | 39 | 2.75% | 92 | 17.95% | 50 | -5.66% |
| Jun 30, 2026 | 167 | 9.87% | 116,099,374 | -6.58% | 37 | 2.26% | 77 | 1.32% | 53 | 60.61% |
| Mar 31, 2026 | 123 | -20.65% | 57,774,841 | -46.71% | 19 | 1.47% | 63 | -19.23% | 22 | -47.62% |
| Dec 31, 2025 | 33 | -78.71% | 3,299,502 | -96.83% | 1 | 0.09% | 12 | -85.19% | 12 | -67.57% |
| Sep 30, 2025 | 53 | -60.15% | 12,673,344 | -88.22% | 4 | 0.32% | 24 | -57.89% | 17 | -61.36% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| American Funds SMALLCAP World A | 13.23M | 4.08% | - |
| Allianz Global Artfcl Intlgc W EUR | 6.17M | 2.07% | -7.81K |
| UBS (Lux) Digital Health Equity SB USD | 4.50M | 1.51% | - |
| SMDS Global AI Equity Mother | 4.49M | 1.50% | - |
| Baillie Gifford Positive Change | 3.89M | 1.30% | -143.60K |
| Baillie Gifford Positive Change B Acc | 3.89M | 1.30% | -128.37K |
| American Funds IS® Asset Allocation 1 | 2.87M | 0.97% | - |
| Baillie Gifford WW Pstv Chg B USD Acc | 2.26M | 0.76% | -72.26K |
| iShares Biotechnology ETF | 1.93M | 0.60% | -12.48K |
| ACATIS Datini Valueflex Fonds A | 1.86M | 0.57% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 13, 2026 | Booth Andrew | Chief Financial Officer | Buy | $97.44K |
| Nov 12, 2026 | Thermopylae Holdings Ltd. | - | Buy | $698.92K |
| Aug 24, 2026 | Hayden Michael R | - | Buy | $570.44K |
| Aug 18, 2026 | Montalbano John S. | - | Buy | $110.30K |
| Aug 14, 2026 | Booth Andrew | Chief Financial Officer | Buy | $383.90K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q4 | 2 | - |
| 2026 Q3 | 4 | - |
| 2026 Q2 | 1 | - |
| 2026 Q1 | 3 | - |
| 2025 Q4 | 1 | - |
ABCL Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools